SynthesisFrontiers in immunology2025

Efficacy and safety of upadacitinib for patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis.

Rui Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.